Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Next generation sequencing of a unique set of glycovariant MC38 mouse colorectal cancer cell lines generated with CRISPR-Cas9 and CRISPR-dCas-VPR technology

ABSTRACT: Next generation sequencing of a unique set of glycovariant MC38 mouse colorectal cancer cell lines generated with CRISPR-Cas9 and CRISPR-dCas-VPR technology

PROVIDER: PRJNA601332 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR10897438.fastq.gz	Fastqsanger.gz
	SRR10897439.fastq.gz	Fastqsanger.gz
	SRR10897440.fastq.gz	Fastqsanger.gz
	SRR10897441.fastq.gz	Fastqsanger.gz
	SRR10897442.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 24

Similar Datasets

Next generation sequencing of a unique set of glycovariant MC38 mouse colorectal cancer cell lines generated with CRISPR-Cas9 and CRISPR-dCas-VPR technology

Project description:To investigate the effect of different tumor-associated glycans, mouse colorectal cancer cells (MC38 cell line) were genetically modified using CRISPR-Cas9 and CRISPR-dCas-VPR technology targeting different genes involved in glycosylation pathways. To study the effect of altered glycosylation at the transcriptional level, next generation sequencing was performed on the entire panel of glycovariant MC38 cell lines. The MC38 knockout cell lines created with the CRISPR-Cas9 technology are: MC38-MOCK#1, MC38-CMAS KO, MC38-COSMC KO, MC38-CMAS+COSMC KO. The MC38 overexpressing cell lines generated with the CRISPR-dCas9-VPR technology are: MC38-MOCK#2, MC38-FUT4, MC38-FUT9. Details on the cell lines can be found in the corresponding manuscript(s).

2020-08-05 | GSE143700 | GEO

Effects of inducible HIV-1 Vpr protein on cellular gene expression

Project description:Three 293 cell-derivative cell line were constructed using commercially available Invitrogen Flp-In TREx 293 cells. The cell lines express wild type HIV-1 Vpr and two mutant Vprs, F72A/R73A and R80A. The mutant Vprs are defective in the Vpr cell cycle arrest phenotype. The cell lines were characterized for their ability to express Vpr at the RNA and protein levels and functionally for the ability of the inducibly expressed Vprs to arrest cell cycle progression at G2/M. To study whether certain host cell genes showed alterations in expression following induced expression of Vpr, we conducted a large scale host cell gene expression profiling study using microarray technologies. To determine whether the differential expression of certain genes was associated with Vpr-induced cell cycle arrest, we compared the gene expression pattern of wild type Vpr expressing cells with the pattern of Vpr mutant F72A/R73A- or R80A-Vpr expressing cells. Doxycycline-induced and uninduced and Flp-In TREx 293/Vpr cells were collected 0, 1, 2, 4, 6, 8, 12, 16 and 24 hours post induction (hpi). Doxycyclineinduced and uninduced Flp-In TREx 293/Blank cells were also collected as a reference for following experiments. Total RNA was isolated using RNAeasy Midi Kit (QIAGEN), according to the manufacturer's protocol. Human long oligonucleotide microarrays were obtained from the National Cancer Institute Microarray Facility, Advanced Technology Center (Gaithersburg, MD). The microarrays (Hs Operon V2) contained 22,434 oligonucleotide (60-70 mer) spots on a glass slide. 25 µg of total RNAs isolated from doxycycline-induced Flp-In TREx 293 stably transfected blank- and FLAG tagged-Vpr cells were reverse transcribed using an oligo (dT) primer and aminoallyl-dNTP (Amersham Pharmacia). Unincorporated dNTPs were removed with QIAquick PCR purification kit (QIAGEN). Purified cDNA was processed for coupling reaction with Cy 5 or Cy 3-ester dye, respectively. Keywords: other

2006-02-10 | GSE2296 | GEO

Enhanced RNA-targeting CRISPR-Cas technology in zebrafish

Project description:Enhanced RNA-targeting CRISPR-Cas technology in zebrafish

| PRJNA1128082 | ENA

Transcriptomic analysis of Pepck-Vpr mouse kidney

Project description:We analyzed the transcriptomic profiles Pepck-Vpr mouse kidney by single-nuclear RNA-seq.

2024-06-12 | GSE223777 | GEO

Enhanced RNA-targeting CRISPR-Cas technology in zebrafish V

Project description:Enhanced RNA-targeting CRISPR-Cas technology in zebrafish V

| PRJNA1197382 | ENA

Exploiting CRISPR-Cas9 technology to investigate individual histone modifications

Project description:Exploiting CRISPR-Cas9 technology to investigate individual histone modifications

| PRJEB21645 | ENA

Enhanced RNA-targeting CRISPR-Cas technology in zebrafish III

Project description:Enhanced RNA-targeting CRISPR-Cas technology in zebrafish III

| PRJNA1127457 | ENA

Enhanced RNA-targeting CRISPR-Cas technology in zebrafish IV

Project description:Enhanced RNA-targeting CRISPR-Cas technology in zebrafish IV

| PRJNA1127458 | ENA

Enhanced RNA-targeting CRISPR-Cas technology in zebrafish I

Project description:Enhanced RNA-targeting CRISPR-Cas technology in zebrafish I

| PRJNA1127455 | ENA

Enhanced RNA-targeting CRISPR-Cas technology in zebrafish II

Project description:Enhanced RNA-targeting CRISPR-Cas technology in zebrafish II

| PRJNA1127456 | ENA

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data